术前使用依诺肝素与未分离肝素相比,增加急性冠脉综合征患者心内直视手术后再次出血的发生率:临床调查和报告

Heath U. Jones, J. Muhlestein, Kent W. Jones, T. Bair, F. Lavasani, Mahtab Sohrevardi, B. Horne, D. Doty, D. Lappé
{"title":"术前使用依诺肝素与未分离肝素相比,增加急性冠脉综合征患者心内直视手术后再次出血的发生率:临床调查和报告","authors":"Heath U. Jones, J. Muhlestein, Kent W. Jones, T. Bair, F. Lavasani, Mahtab Sohrevardi, B. Horne, D. Doty, D. Lappé","doi":"10.1161/01.CIR.0000032917.33237.E0","DOIUrl":null,"url":null,"abstract":"BackgroundEnoxaparin has become an attractive therapy for use during acute coronary syndrome (ACS) because of its potential superior efficacy over unfractionated heparin (UFH), its longer activity, and its subcutaneous route of administration. However, because a significant number of patients presenting with ACS may be sent directly to open heart surgery while still on anticoagulation, it is important to understand any potential bleeding risks that may be associated with the use of enoxaparin under these circumstances. MethodsFrom 1998 to 2001, 1159 consecutive patients presenting with an acute coronary syndrome who received either UFH (n=1008) or enoxaparin (n=151) before proceeding to open heart surgery for urgent therapy during the same hospitalization were included in this study. Incidence of perioperative bleeding as evidenced by the units of blood products (packed red blood cells or platelets) transfused or the need for surgical re-exploration for postoperative bleeding was recorded. ResultsAverage age was 65±11 and 67±11 years for patients receiving UFH and enoxaparin, respectively (P= 0.005). Seventy-five percent of those receiving UFH and 64% of those receiving enoxaparin (P <0.005) were males. After discharge, the incidence of rehospitalization for hemorrhage requiring return to surgery for re-exploration was 7.9% in the enoxaparin group and 3.7% in the UFH group (adjusted hazard ratio=2.6, P =0.03). The use of blood products did not differ between groups (UFH=2.7±6.5 U and enoxaparin=2.3±4.5 U;P =NS). ConclusionThe preoperative use of enoxaparin compared with UFH in patients presenting with an ACS who undergo open-heart surgery during the same hospitalization is associated with a significantly increased incidence of re-exploration for postoperative bleeding. Further study is needed to understand the mechanism of this phenomenon and to develop appropriate guidelines to address this potentially important issue.","PeriodicalId":10194,"journal":{"name":"Circulation: Journal of the American Heart Association","volume":"86 1","pages":"I-19-I-22"},"PeriodicalIF":0.0000,"publicationDate":"2002-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"79","resultStr":"{\"title\":\"Preoperative Use of Enoxaparin Compared With Unfractionated Heparin Increases the Incidence of Re-Exploration for Postoperative Bleeding After Open-Heart Surgery in Patients Who Present With an Acute Coronary Syndrome: Clinical Investigation and Reports\",\"authors\":\"Heath U. Jones, J. Muhlestein, Kent W. Jones, T. Bair, F. Lavasani, Mahtab Sohrevardi, B. Horne, D. Doty, D. Lappé\",\"doi\":\"10.1161/01.CIR.0000032917.33237.E0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"BackgroundEnoxaparin has become an attractive therapy for use during acute coronary syndrome (ACS) because of its potential superior efficacy over unfractionated heparin (UFH), its longer activity, and its subcutaneous route of administration. However, because a significant number of patients presenting with ACS may be sent directly to open heart surgery while still on anticoagulation, it is important to understand any potential bleeding risks that may be associated with the use of enoxaparin under these circumstances. MethodsFrom 1998 to 2001, 1159 consecutive patients presenting with an acute coronary syndrome who received either UFH (n=1008) or enoxaparin (n=151) before proceeding to open heart surgery for urgent therapy during the same hospitalization were included in this study. Incidence of perioperative bleeding as evidenced by the units of blood products (packed red blood cells or platelets) transfused or the need for surgical re-exploration for postoperative bleeding was recorded. ResultsAverage age was 65±11 and 67±11 years for patients receiving UFH and enoxaparin, respectively (P= 0.005). Seventy-five percent of those receiving UFH and 64% of those receiving enoxaparin (P <0.005) were males. After discharge, the incidence of rehospitalization for hemorrhage requiring return to surgery for re-exploration was 7.9% in the enoxaparin group and 3.7% in the UFH group (adjusted hazard ratio=2.6, P =0.03). The use of blood products did not differ between groups (UFH=2.7±6.5 U and enoxaparin=2.3±4.5 U;P =NS). ConclusionThe preoperative use of enoxaparin compared with UFH in patients presenting with an ACS who undergo open-heart surgery during the same hospitalization is associated with a significantly increased incidence of re-exploration for postoperative bleeding. Further study is needed to understand the mechanism of this phenomenon and to develop appropriate guidelines to address this potentially important issue.\",\"PeriodicalId\":10194,\"journal\":{\"name\":\"Circulation: Journal of the American Heart Association\",\"volume\":\"86 1\",\"pages\":\"I-19-I-22\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2002-09-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"79\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Circulation: Journal of the American Heart Association\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1161/01.CIR.0000032917.33237.E0\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Circulation: Journal of the American Heart Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1161/01.CIR.0000032917.33237.E0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 79

摘要

脱氧肝素已成为急性冠脉综合征(ACS)的一种有吸引力的治疗方法,因为它的潜在疗效优于未分离肝素(UFH),其活性更长,并且其皮下给药途径。然而,由于大量出现ACS的患者可能在抗凝治疗期间直接接受心脏直视手术,因此了解在这种情况下使用依诺肝素可能存在的潜在出血风险是很重要的。方法:从1998年到2001年,1159例急性冠脉综合征患者在同一住院期间接受了UFH (n=1008)或依诺肝素(n=151),然后进行心脏直视手术进行紧急治疗。记录围手术期出血的发生率,以输血的血制品(填充红细胞或血小板)单位为证据,或术后出血需要再次手术探查。结果接受UFH和依诺肝素治疗的患者平均年龄分别为65±11岁和67±11岁(P= 0.005)。75%接受UFH治疗的患者为男性,64%接受依诺肝素治疗的患者为男性(P <0.005)。出院后,依诺肝素组因出血再次住院需要再次手术探查的发生率为7.9%,UFH组为3.7%(校正风险比=2.6,P =0.03)。两组间血液制品的使用无差异(UFH=2.7±6.5 U,依诺肝素=2.3±4.5 U;P =NS)。结论:在同一住院期间行心内直视手术的ACS患者,术前使用依诺肝素与使用UFH相比,术后再探查出血的发生率显著增加。需要进一步研究以了解这一现象的机制,并制定适当的指导方针来解决这一潜在的重要问题。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Preoperative Use of Enoxaparin Compared With Unfractionated Heparin Increases the Incidence of Re-Exploration for Postoperative Bleeding After Open-Heart Surgery in Patients Who Present With an Acute Coronary Syndrome: Clinical Investigation and Reports
BackgroundEnoxaparin has become an attractive therapy for use during acute coronary syndrome (ACS) because of its potential superior efficacy over unfractionated heparin (UFH), its longer activity, and its subcutaneous route of administration. However, because a significant number of patients presenting with ACS may be sent directly to open heart surgery while still on anticoagulation, it is important to understand any potential bleeding risks that may be associated with the use of enoxaparin under these circumstances. MethodsFrom 1998 to 2001, 1159 consecutive patients presenting with an acute coronary syndrome who received either UFH (n=1008) or enoxaparin (n=151) before proceeding to open heart surgery for urgent therapy during the same hospitalization were included in this study. Incidence of perioperative bleeding as evidenced by the units of blood products (packed red blood cells or platelets) transfused or the need for surgical re-exploration for postoperative bleeding was recorded. ResultsAverage age was 65±11 and 67±11 years for patients receiving UFH and enoxaparin, respectively (P= 0.005). Seventy-five percent of those receiving UFH and 64% of those receiving enoxaparin (P <0.005) were males. After discharge, the incidence of rehospitalization for hemorrhage requiring return to surgery for re-exploration was 7.9% in the enoxaparin group and 3.7% in the UFH group (adjusted hazard ratio=2.6, P =0.03). The use of blood products did not differ between groups (UFH=2.7±6.5 U and enoxaparin=2.3±4.5 U;P =NS). ConclusionThe preoperative use of enoxaparin compared with UFH in patients presenting with an ACS who undergo open-heart surgery during the same hospitalization is associated with a significantly increased incidence of re-exploration for postoperative bleeding. Further study is needed to understand the mechanism of this phenomenon and to develop appropriate guidelines to address this potentially important issue.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信